NYSEAMERICAN : INFU
InfuSystem Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 14.07 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 280.23M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 280.23M |
| Enterprise Value | 303.80M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 19.92M |
| Shares Outstanding | 19.92M |
| Shares Change (YoY) | -3.70% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 5.64% |
| Owned by Institutions (%) | 78.27% |
| Float | 18.79M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 35.10 |
| Forward PE | 29.11 |
| PS Ratio | 1.96 |
| Forward PS | 1.88 |
| PB Ratio | 4.74 |
| P/TBV Ratio | 5.72 |
| P/FCF Ratio | 22.33 |
| P/OCF Ratio | 11.99 |
| PEG Ratio | 1.16 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 35.56 |
| EV / Sales | 2.12 |
| EV / EBITDA | 12.54 |
| EV / EBIT | 26.96 |
| EV / FCF | 24.21 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.50 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | 1.95 |
| Interest Coverage | 10.24 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 15.03% |
| Return on Assets (ROA) | 7.09% |
| Return on Invested Capital (ROIC) | 9.64% |
| Return on Capital Employed (ROCE) | 13.67% |
| Weighted Average Cost of Capital (WACC) | 11.68% |
| Revenue Per Employee | $303,034 |
| Profits Per Employee | $18,061 |
| Employee Count | 473 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 10.90 |
Taxes
| Measure | Value |
|---|
| Income Tax | 3.67M |
| Effective Tax Rate | 30.04% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +33.75% |
| 50-Day Moving Average | 12.97 |
| 200-Day Moving Average | 10.33 |
| Relative Strength Index (RSI) | 58.58 |
| Average Volume (20 Days) | 112,500 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 813,399 |
| Short Previous Month | 812,365 |
| Short % of Shares Out | 4.08% |
| Short % of Float | 4.33% |
| Short Ratio (days to cover) | 6.08 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 143.34M |
| Gross Profit | 82.35M |
| Operating Income | 11.27M |
| Pretax Income | 12.21M |
| Net Income | 8.54M |
| EBITDA | 24.23M |
| EBIT | 11.27M |
| Earnings Per Share (EPS) | $0.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 964,000 |
| Total Debt | 24.53M |
| Net Cash | -23.57M |
| Net Cash Per Share | -$1.18 |
| Equity (Book Value) | 59.15M |
| Book Value Per Share | 2.97 |
| Working Capital | 22.97M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 23.37M |
| Capital Expenditures | -10.82M |
| Depreciation & Amortization | 12.96M |
| Net Borrowing | -5.82M |
| Free Cash Flow | 12.55M |
| FCF Per Share | $0.63 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.45% |
| Operating Margin | 7.86% |
| Pretax Margin | 8.52% |
| Profit Margin | 5.96% |
| EBITDA Margin | 16.90% |
| EBIT Margin | 7.86% |
| FCF Margin | 8.76% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.70% |
| Shareholder Yield | 3.70% |
| Earnings Yield | 2.85% |
| FCF Yield | 4.48% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.83 |
| Price Target Difference | 19.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 4.58% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.11 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |